REFERENCES:

Abu-Rustum NR, Herbolsheimer H. Breast cancer risk assessment in indigent women at a public hospital. Gynecol Oncol 2001;81(2):287-90. Abstract

Anderson S et al. NSABP Breast Cancer Prevention Trial risk assessment program. Version 2. NSABP Biostatistical Center Technical Report; 1992.

Ang P, Garber JE. Genetic susceptibility for breast cancer—risk assessment and counseling. Semin Oncol 2001; 28(4):419-33. Abstract

Armstrong K et al. Assessing the risk of breast cancer. N Engl J Med 2000;342(8):564-71.

Bondy ML, et al. Validation of a breast cancer risk assessment model in women with a positive family history. J Natl Cancer Inst 1994;86:620-5. Abstract

Claus EB. Risk models in genetic epidemiology. Stat Methods Med Res 2000;9(6):589-601. Abstract

Costantino JP et al. Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst 1999;91(18):1541-8. Abstract

Daly MB, Ross EA. Predicting breast cancer: The search for a model. J Natl Cancer Inst 2000;92(15):1196-7. Abstract.

Dupont WD. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer 1993;71(4):1258-65. Abstract

Euhus DM. Understanding mathematical models for breast cancer risk assessment and counseling. Breast J 2001;7(4):224-32. Abstract

Fabian CJ, Kimler BF. Breast cancer risk prediction: Should nipple aspiration fluid cytology be incorporated into clinical practice? J Natl Cancer Inst 2001;93(23):1762-3. Abstract.

Fisher B et al. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998;90:1371-88. Abstract

Gail MH et al. Projecting individualized probabilities of developing beast cancer for whiete females who are being examined annually. J Natl Cancer Inst 1989;81:1879-86. Abstract

Gail MH, Costantino JP. Validating and improving models for projecting the absolute risk of breast cancer. J Natl Cancer Inst 2001;93(5):334-5. Abstract.

Garber J. A 40-year-old woman with a strong family history of breast cancer. JAMA 1999;282(20):1953-60. Abstract.

Glasspool DW et al. Risk assessment in genetics: A semi-quantitative approach. Medinfo 2001;10(Pt 1):459-63. Abstract

Hoskins KF et al. Assessment and counseling for women with a family history of breast cancer. A guide for clinicians. JAMA 1995;273(7):577-85. Abstract

Hurt GJ et al. Risk assessment of first-degree relatives of women with breast cancer: a feasibility study. Oncol Nurs Forum 2001;28(7):1097-104. Abstract

Kelly PT. Hereditary Breast Cancer: Risk Assessment Is the Easy Part. Breast J 1999;5(1):52-58. Abstract

King MC et al. Inherited breast and ovarian cancer. What are the risks? What are the choices? JAMA 1993;269(15):1975-80. Abstract.

Krieger N, Hiatt RA. Risk of breast cancer after benign breast diseases. Variation by histologic type, degree of atypia, age at biopsy, and length of follow-up. Am J Epidemiol 1992;135(6):619-31. Abstract

Lipkus IM et al. Communicating breast cancer risks to women using different formats. Cancer Epidemiol Biomarkers Prev 2001;10(8):895-8. Abstract

London SJ et al. A prospective study of benign breast disease and the risk of breast cancer. JAMA 1992;267(7):941-4. Abstract

MacKarem G et al. The effectiveness of the Gail model in estimating risk for development of breast cancer in women under 40 years of age. Breast J 2001;7(1):34-9. Abstract

Marshall LM et al. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev 1997;6:297-301. Abstract

Masood S. Breast cancer risk assessment: Who holds the magic crystal ball? Breast J 2001;7(3):143. Abstract.

McTiernan A et al. Comparisons of two breast cancer risk estimates in women with a family history of breast cancer. Cancer Epidemiol Biomarkers Prev 2001;10(4):333-8. Abstract

Rhodes DJ et al. Breast cancer prevention trials. Curr Oncol Rep 2000;2(6):558-65. Abstract

Rockhill B et al. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst 2001;93(5):358-66. Abstract

Rose PW et al. Referral of patients with a family history of breast/ovarian cancer—GPs’ knowledge and expectations. Fam Pract 2001;18(5):487-90. Abstract

Spiegelman D et al. Validation of the Gail et al. model for predicting individual breast cancer risk. J Natl Cancer Inst 1994;86:600-7. Abstract

Walter FM et al. Experiences and expectations of the new genetics in relation to familial risk of breast cancer: A comparison of the views of GPs and practice nurses. Fam Pract 2001;18(5):491-4. Abstract

Back | Top of Page